Search research articles
Contact Us
Filters
Showing results (101-110 of 191) with videos related to
Page
of 20
Sort By:
The Journal of Urology
|
January 6, 2021
Reply by Authors
Steven Rosenberg, Marc Bonten, Wouter Haazen, et al.
Human Vaccines & Immunotherapeutics
|
December 16, 2020
Safety and immunogenicity of an adjuvanted <i>Escherichia coli</i> adhesin vaccine in healthy women with and without histories of recurrent urinary tract infections: results from a first-in-human phase 1 study
Gary R Eldridge, Heidi Hughey, Lois Rosenberger, et al.
Urologic Oncology
|
October 7, 2023
Bladder cancer patient and provider perspectives on smoking cessation
Matthew Mossanen, Angela B Smith, Nnamdi Onochie, et al.
The Journal of Urology
|
October 20, 2020
Epidemiology and O-Serotypes of Extraintestinal Pathogenic <i>Escherichia coli</i> Disease in Patients Undergoing Transrectal Ultrasound Prostate Biopsy: A Prospective Multicenter Study
Steven Rosenberg, Marc Bonten, Wouter Haazen, et al.
BJU International
|
December 2, 2011
Testosterone in prostate cancer: the Bethesda consensus
Bob Djavan, James Eastham, Leonard Gomella, et al.
Urology
|
February 5, 2025
Implementing and Optimizing Universal Germline Genetic Testing for Patients With Prostate Cancer in Clinical Practice
Neal Shore, Andrew J Armstrong, Pedro Barata, et al.
Prostate Cancer and Prostatic Diseases
|
December 9, 2025
Efficacy and safety of treatments for metastatic castration-sensitive prostate cancer: A comprehensive network meta-analysis including final ARANOTE data
Neal Shore, Alicia K Morgans, Noman Paracha, et al.
Future Oncology (London, England)
|
August 17, 2016
Treatment registry for outcomes in patients with castration-resistant prostate cancer (TRUMPET): a methodology for real-world evidence and research
David F Penson, Daniel W Lin, Lawrence Karsh, et al.
Future Oncology (London, England)
|
May 19, 2021
Perioperative pembrolizumab therapy in muscle-invasive bladder cancer: Phase III KEYNOTE-866 and KEYNOTE-905/EV-303
Matthew D Galsky, Christopher J Hoimes, Andrea Necchi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 16, 2021
Consistent survival benefit of enzalutamide plus androgen deprivation therapy in men with nonmetastatic castration-resistant prostate cancer: PROSPER subgroup analysis by age and region
Ugo De Giorgi, Maha Hussain, Neal Shore, et al.
Page
of 20
Search research articles
Search
Showing results (101-110 of 191) with videos related to
Sort By:
Page
of 20
The Journal of Urology
|
January 6, 2021
Reply by Authors
Steven Rosenberg, Marc Bonten, Wouter Haazen, et al.
Human Vaccines & Immunotherapeutics
|
December 16, 2020
Safety and immunogenicity of an adjuvanted <i>Escherichia coli</i> adhesin vaccine in healthy women with and without histories of recurrent urinary tract infections: results from a first-in-human phase 1 study
Gary R Eldridge, Heidi Hughey, Lois Rosenberger, et al.
Urologic Oncology
|
October 7, 2023
Bladder cancer patient and provider perspectives on smoking cessation
Matthew Mossanen, Angela B Smith, Nnamdi Onochie, et al.
The Journal of Urology
|
October 20, 2020
Epidemiology and O-Serotypes of Extraintestinal Pathogenic <i>Escherichia coli</i> Disease in Patients Undergoing Transrectal Ultrasound Prostate Biopsy: A Prospective Multicenter Study
Steven Rosenberg, Marc Bonten, Wouter Haazen, et al.
BJU International
|
December 2, 2011
Testosterone in prostate cancer: the Bethesda consensus
Bob Djavan, James Eastham, Leonard Gomella, et al.
Urology
|
February 5, 2025
Implementing and Optimizing Universal Germline Genetic Testing for Patients With Prostate Cancer in Clinical Practice
Neal Shore, Andrew J Armstrong, Pedro Barata, et al.
Prostate Cancer and Prostatic Diseases
|
December 9, 2025
Efficacy and safety of treatments for metastatic castration-sensitive prostate cancer: A comprehensive network meta-analysis including final ARANOTE data
Neal Shore, Alicia K Morgans, Noman Paracha, et al.
Future Oncology (London, England)
|
August 17, 2016
Treatment registry for outcomes in patients with castration-resistant prostate cancer (TRUMPET): a methodology for real-world evidence and research
David F Penson, Daniel W Lin, Lawrence Karsh, et al.
Future Oncology (London, England)
|
May 19, 2021
Perioperative pembrolizumab therapy in muscle-invasive bladder cancer: Phase III KEYNOTE-866 and KEYNOTE-905/EV-303
Matthew D Galsky, Christopher J Hoimes, Andrea Necchi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 16, 2021
Consistent survival benefit of enzalutamide plus androgen deprivation therapy in men with nonmetastatic castration-resistant prostate cancer: PROSPER subgroup analysis by age and region
Ugo De Giorgi, Maha Hussain, Neal Shore, et al.
Page
of 20